706 related articles for article (PubMed ID: 28463465)
1. Dendritic cell-targeting DNA-based nasal adjuvants for protective mucosal immunity to Streptococcus pneumoniae.
Kataoka K; Fukuyama Y; Briles DE; Miyake T; Fujihashi K
Microbiol Immunol; 2017 Jun; 61(6):195-205. PubMed ID: 28463465
[TBL] [Abstract][Full Text] [Related]
2. Mucosal immune features to phosphorylcholine by nasal Flt3 ligand cDNA-based vaccination.
Baatarjav T; Kataoka K; Gilbert RS; Terao Y; Fukui M; Goto M; Kawabata S; Yamamoto M; Fujihashi K; Ito HO
Vaccine; 2011 Aug; 29(34):5747-57. PubMed ID: 21683111
[TBL] [Abstract][Full Text] [Related]
3. A combination of Flt3 ligand cDNA and CpG oligodeoxynucleotide as nasal adjuvant elicits protective secretory-IgA immunity to Streptococcus pneumoniae in aged mice.
Fukuyama Y; King JD; Kataoka K; Kobayashi R; Gilbert RS; Hollingshead SK; Briles DE; Fujihashi K
J Immunol; 2011 Feb; 186(4):2454-61. PubMed ID: 21242514
[TBL] [Abstract][Full Text] [Related]
4. The nasal dendritic cell-targeting Flt3 ligand as a safe adjuvant elicits effective protection against fatal pneumococcal pneumonia.
Kataoka K; Fujihashi K; Oma K; Fukuyama Y; Hollingshead SK; Sekine S; Kawabata S; Ito HO; Briles DE; Oishi K
Infect Immun; 2011 Jul; 79(7):2819-28. PubMed ID: 21536790
[TBL] [Abstract][Full Text] [Related]
5. Compound 48/80 acts as a potent mucosal adjuvant for vaccination against Streptococcus pneumoniae infection in young mice.
Zeng L; Liu Y; Wang H; Liao P; Song Z; Gao S; Wu Y; Zhang X; Yin Y; Xu W
Vaccine; 2015 Feb; 33(8):1008-16. PubMed ID: 25595867
[TBL] [Abstract][Full Text] [Related]
6. Intranasal immunization with pneumococcal surface protein A in the presence of nanoparticle forming polysorbitol transporter adjuvant induces protective immunity against the Streptococcus pneumoniae infection.
Kye YC; Park SM; Shim BS; Firdous J; Kim G; Kim HW; Ju YJ; Kim CG; Cho CS; Kim DW; Cho JH; Song MK; Han SH; Yun CH
Acta Biomater; 2019 May; 90():362-372. PubMed ID: 30922953
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylcholine intranasal immunization with a 13-valent pneumococcal conjugate vaccine can boost immune response against Streptococcus pneumoniae.
Ohori J; Iuchi H; Maseda Y; Kurono Y
Vaccine; 2020 Jan; 38(3):699-704. PubMed ID: 31668823
[TBL] [Abstract][Full Text] [Related]
8. Nasal immunization with recombinant chimeric pneumococcal protein and cell wall from immunobiotic bacteria improve resistance of infant mice to Streptococcus pneumoniae infection.
Laiño J; Villena J; Suvorov A; Zelaya H; Ortiz Moyano R; Salva S; Alvarez S
PLoS One; 2018; 13(11):e0206661. PubMed ID: 30395582
[TBL] [Abstract][Full Text] [Related]
9. Role of antibodies and IL17-mediated immunity in protection against pneumococcal otitis media.
Habets MN; van Selm S; van Opzeeland FJ; Simonetti E; Hermans PWM; de Jonge MI; Diavatopoulos DA
Vaccine; 2016 Nov; 34(48):5968-5974. PubMed ID: 27771185
[TBL] [Abstract][Full Text] [Related]
10. Nanogel-based PspA intranasal vaccine prevents invasive disease and nasal colonization by Streptococcus pneumoniae.
Kong IG; Sato A; Yuki Y; Nochi T; Takahashi H; Sawada S; Mejima M; Kurokawa S; Okada K; Sato S; Briles DE; Kunisawa J; Inoue Y; Yamamoto M; Akiyoshi K; Kiyono H
Infect Immun; 2013 May; 81(5):1625-34. PubMed ID: 23460513
[TBL] [Abstract][Full Text] [Related]
11. Host immunity in the protective response to nasal immunization with a pneumococcal antigen associated to live and heat-killed Lactobacillus casei.
Vintiñi EO; Medina MS
BMC Immunol; 2011 Aug; 12():46. PubMed ID: 21834957
[TBL] [Abstract][Full Text] [Related]
12. Nasal vaccination with pneumococcal surface protein A in combination with cationic liposomes consisting of DOTAP and DC-chol confers antigen-mediated protective immunity against Streptococcus pneumoniae infections in mice.
Tada R; Suzuki H; Takahashi S; Negishi Y; Kiyono H; Kunisawa J; Aramaki Y
Int Immunopharmacol; 2018 Aug; 61():385-393. PubMed ID: 29945026
[TBL] [Abstract][Full Text] [Related]
13. Respiratory FimA-Specific Secretory IgA Antibodies Upregulated by DC-Targeting Nasal Double DNA Adjuvant Are Essential for Elimination of
Kataoka K; Kawabata S; Koyanagi K; Hashimoto Y; Miyake T; Fujihashi K
Front Immunol; 2021; 12():634923. PubMed ID: 33717178
[TBL] [Abstract][Full Text] [Related]
14. A nasal double DNA adjuvant system induces atheroprotective IgM antibodies via dendritic cell-B-1a B cell interactions.
Yoshimatsu H; Kataoka K; Fujihashi K; Miyake T; Ono Y
Vaccine; 2022 Feb; 40(8):1116-1127. PubMed ID: 35086743
[TBL] [Abstract][Full Text] [Related]
15. Protection elicited by nasal immunization with pneumococcal surface protein A (PspA) adjuvanted with bacterium-like particles against Streptococcus pneumoniae infection in mice.
Li B; Chen X; Yu J; Zhang Y; Mo Z; Gu T; Kong W; Wu Y
Microb Pathog; 2018 Oct; 123():115-119. PubMed ID: 29959043
[TBL] [Abstract][Full Text] [Related]
16. Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice.
Nguyen CT; Kim SY; Kim MS; Lee SE; Rhee JH
Vaccine; 2011 Aug; 29(34):5731-9. PubMed ID: 21696869
[TBL] [Abstract][Full Text] [Related]
17. Novel protein-based pneumococcal vaccines administered with the Th1-promoting adjuvant IC31 induce protective immunity against pneumococcal disease in neonatal mice.
Olafsdottir TA; Lingnau K; Nagy E; Jonsdottir I
Infect Immun; 2012 Jan; 80(1):461-8. PubMed ID: 22025519
[TBL] [Abstract][Full Text] [Related]
18. Intranasal vaccination with pneumococcal surface protein A and interleukin-12 augments antibody-mediated opsonization and protective immunity against Streptococcus pneumoniae infection.
Arulanandam BP; Lynch JM; Briles DE; Hollingshead S; Metzger DW
Infect Immun; 2001 Nov; 69(11):6718-24. PubMed ID: 11598043
[TBL] [Abstract][Full Text] [Related]
19. Oral immunization with PspA elicits protective humoral immunity against Streptococcus pneumoniae infection.
Yamamoto M; McDaniel LS; Kawabata K; Briles DE; Jackson RJ; McGhee JR; Kiyono H
Infect Immun; 1997 Feb; 65(2):640-4. PubMed ID: 9009325
[TBL] [Abstract][Full Text] [Related]
20. Intranasal immunization with phosphorylcholine induces antigen specific mucosal and systemic immune responses in mice.
Tanaka N; Fukuyama S; Fukuiwa T; Kawabata M; Sagara Y; Ito HO; Miwa Y; Nagatake T; Kiyono H; Kurono Y
Vaccine; 2007 Mar; 25(14):2680-7. PubMed ID: 17270319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]